Apollomics CEO Holds Firm: Quiet RSU Vesting Signals Long‑Term Confidence Amid Biotech Volatility
Apollomics CEO’s steady shareholding and RSU vesting signal long‑term confidence and potential growth—watch for clinical milestones that could spark a price rally.
3 minutes to read